Fibrinolytic therapy
- Agents: Fibrinolytics promote the degradation of thrombi by activating plasminogen to plasmin.
- Adverse effects
- Bleeding (e.g., intracranial hemorrhage)
- Reversal of adverse effects
- Antifibrinolytics: group of drugs that impair fibrinolysis, typically by interfering with plasmin formation
- Tranexamic acid: a synthetic lysine analog and inhibitor of plasminogen with antifibrinolytic action
- Aminocaproic acid: a lysine derivative and inhibitor of plasminogen activators and plasmin with antifibrinolytic action